CPHI Middle East

Hosted in Riyadh, the event brings together companies spanning ingredients, finished dosage, contract services, biopharma, machinery and equipment, packaging and drug delivery, and related solutions. It’s designed for sourcing, partnership-building and market insight—particularly for organisations looking to expand or deepen their presence in Saudi Arabia and the wider region.

Who the audience is and how many attend

Audience

• API and excipient suppliers, intermediates and chemical manufacturers
• Finished-dosage and generic manufacturers
• CDMOs/CMOs and outsourcing partners
• Biopharma and biotech companies and enabling technology providers
• Packaging, machinery, processing and quality/regulatory solution providers
• Procurement, supply chain and manufacturing leadership teams

Scale

• Participating companies: 1,000+ pharma companies promoted as part of the event ecosystem
• The organiser does not consistently publish a single fixed headline figure for total attendees/exhibitors on the main overview pages.

What to expect

• A large exhibition floor covering the end-to-end pharma value chain (ingredients, manufacturing, packaging and services)
• High-density sourcing and business development meetings with regional and international suppliers
• Conference and content programmes addressing market trends, regulation and manufacturing priorities relevant to the Middle East
• Strong networking focused on partnerships, localisation opportunities and regional market access pathways